US Cell Surface Markers: Hospitals, Commercial Labs, Ambulatory Care Centers, Physician Offices--Emerging Opportunities for Instrument and Reagent Suppliers--Competitive Strategies, Country Volume & Sales Segment Forecasts

June 2016 | 115 pages | ID: UF3302BA125EN
Venture Planning Group

Abstracts

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by market segment.

Contents

I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Lymphocyte Subclassification CD4/CD8/CD34
      Instrumentation and Reagent Test Kits
      BD

      Beckman Coulter/Danaher
      T Cells Diagnostics

B. CD34

C. Other Cell Markers
D. Instrumentation Review
  1. HEMATOLOGY ANALYZERS
    a. Overview
      Electrical ApertureImpedance Analyzers
      Light Scatter Analyzers
    b. System Review
      Abbott
      Beckman Coulter/Danaher
      Biocode Hycel
      DrewScientific
      Horiba
      Menarini
      Nihon Kohden
      Siemens
      Sysmex
  2. FLOW CYTOMETERS
    a. INTRODUCTION
    b. System Overview
      Becton Dickinson
      Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
  1. INFORMATION TECHNOLOGIES
  2. AUTOMATION AND ROBOTICS
  3. LASERS
  4. ARTIFICIAL INTELLIGENCE
  5. MONOCLONAL ANTIBODIES
  6. MOLECULAR DIAGNOSTICS
  7. MICRODROP TECHNOLOGY
III. U.S. : Forecasts by Test and Market Segment

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized

TESTING MARKETS

  1. FOUR MARKETING APPROACHES
  2. PRODUCT COMPLEXITY FACTOR
  3. CUSTOMER PREFERENCE FACTOR
  4. ESTABLISHED SUPPLIERS
  5. EMERGING SUPPLIERS
  6. MAJOR TYPES OF DISTRIBUTORS
  7. MARKET SEGMENTATION FACTOR

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. COMPETITIVE ASSESSMENTS

      Abbott
      Agilent Technologies
      Beckman Coulter/Danaher
      Becton Dickinson
      BioRad
      CellaVision
      Horiba
      Iris/Danaher
      Nihon Kohden
      OrthoClinical Diagnostics
      Roche
      Siemens
      Sysmex
VII. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications

List Of Tables

LIST OF TABLES

U.S., Hospital Laboratories Estimated
Cell Surface Marker Test Volume U.S., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume U.S., Physician Office Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Flow Cytometry Consumables Market By Major Supplier
U.S., Flow Cytometry Instrument Market By Major Supplier
U.S., Flow Cytometry Diagnostics Market By Major Supplier